非線形HbA1cの値は,2型糖尿病における加速されたアテロゲン再構成と改善されたリスク再分類を明らかにする
Vehbi Şirikçi1, Hüseyin Avni Fındıklı1
1Internal Medicine Department, Necip Fazil City Hospital, Kahramanmaras, Türkiye.
Frontiers in cardiovascular medicine
|February 16, 2026
まとめ
2型糖尿病では,HbA1cレベルが8.0%から8.5%の範囲にあると,脂質不全症による心血管疾患のリスクが増加したことを示します. Atherogenic Index of Plasma (AIP) は,トリグリセリドとHDLコレステロールの比率をキーメディエーターとして,このリスクを検出するのに役立ちます.
科学分野:
- 心臓病学 心臓病学
- エンドクリノロジー エンドクリノロジー
- メタボリックシンドロームとは
背景:
- 2型糖尿病 (T2D) は,血糖,脂質代謝,心血管疾患 (CVD) の進行との複雑な相互作用を伴う.
- T2DにおけるCVDの主要な要因であるアテロゲン性脂質不全症は,非線形脂質リモデリングプロセスが十分に定義されていない.
- 加速されたアテロゲネシスのための特定の血糖値の値を特定することは,T2D患者の効果的なCVDリスク管理に不可欠です.
研究 の 目的:
- T2Dにおける加速された脂質駆動性アテロゲネシスに関連したHbA1cの値を決定する.
- 高血糖症と脂質再構成の関係におけるトリグリセリドとHDLコレステロール比 (TG/HDL-C) の媒介的な役割を定量化する.
- "グリセミック・グレー・ゾーン"内の心血管リスクに対するプラズマのアテロゲン指数 (AIP) の予測的付加価値を評価する.
主な方法:
- 脂質低下療法を受けていない271人のT2Dの成人を遡及的に分析し,HbA1cコントロール (<7.0%,7.0%-8.49%,8.5%以上) によってグループ化した.
- AIP,カステリ指数,TG/HDL-C,非HDLコレステロール,残留コレステロールを用いたアテロゲン性脂質負荷の評価.
- 非線形HbA1c-脂質関係のための制限された立方スプリンの適用,TG/HDL-Cの役割のためのメディエーション分析,およびAIPの予測値のための純再分類改善 (NRI) の適用.
主要な成果:
- すべてのアテロゲン性脂質指数は,血糖値の増加とともに著しく悪化した (p < 0.001).
- 非線形の転換点は,HbA1c 8.0%でTG/HDL-Cと8.5%でAIP (p <0.01) で特定されました.
- TG/HDL-Cは,AIPに対するHbA1cの影響の56.9%を媒介した;AIPは,特にHbA1c 8.0%-8.5% (NRI = 0.384) の間で,心臓血管リスク再分類を改善した.
結論:
- 8.0%から8.5%のHbA1cレベルは,加速されたアテロゲン性脂質不全症によって特徴づけられるT2Dにおける代謝的に脆弱な値を表します.
- AIPは,このグリセミックグレーゾーンにおける心代謝リスク検出のための敏感な脂質マーカーとして機能します.
- TG/HDL-Cは,高血糖症と脂質リモデリングを結びつける重要な媒介であり,アテロゲン指標をパーソナライズされたT2D管理に統合することをサポートします.
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
Carbohydrate Metabolism
14.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.4K
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K


